Plandai Biotechnology Inc (PLPL)

[Aston Martin]

tomatotom, PLandai doesn't have enough money to go NASDAQ, SEC filings cost a hell of money and rules are enormous. DD of Institutions is much more intensive and institution buy because of a really existing product which generates significant revenues already. PLPL is still not ready for this till this summer as well as Phytofare needs to receive FDA approval before. No microcap - which has been a shell before - has a chance to go NASDAQ within two years only !